+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acne Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 4852472
  • Report
  • September 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
UP TO OFF
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • ALLERGAN
  • Anterios Inc.
  • Bayer AG
  • Cipher
  • Foamix Pharmaceuticals
  • GlaxoSmithKline Plc.
  • MORE
Acne Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global acne drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the acne drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? the Acne Drugs Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:
1) by Type: Inflammatory Acne; Non-Inflammatory Acne
2) by End User: Hospitals & Clinics; Pharmacies & Drug Stores; Ambulatory Surgical Centres
3) by Therapeutic Class: Retinoids; Antibiotics; Salicylic Acid; Benzoyl Peroxide

Companies Mentioned: ALLERGAN; Galderma S.A.; Valeant Pharmaceutical International; Teva Pharmaceutical Industries Ltd.; Johnson & Johnson Services

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ALLERGAN
  • Anterios Inc.
  • Bayer AG
  • Cipher
  • Foamix Pharmaceuticals
  • GlaxoSmithKline Plc.
  • MORE
1. Executive Summary

2. Acne Drugs Market Characteristics

3. Acne Drugs Market Size And Growth
3.1. Global Acne Drugs Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Acne Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Acne Drugs Market Segmentation
4.1. Global Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Inflammatory Acne Drugs
  • Non-Inflammatory Acne Drugs
4.2. Global Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Ambulatory Surgical Centres
4.3. Global Acne Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Retinoids
  • Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide
5. Acne Drugs Market Regional And Country Analysis
5.1. Global Acne Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Acne Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Acne Drugs Market
6.1. Asia-Pacific Acne Drugs Market Overview
6.2. Asia-Pacific Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Acne Drugs Market
7.1. China Acne Drugs Market Overview
7.2. China Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Acne Drugs Market
8.1. India Acne Drugs Market Overview
8.2. India Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Acne Drugs Market
9.1. Japan Acne Drugs Market Overview
9.2. Japan Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Acne Drugs Market
10.1. Australia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Acne Drugs Market
11.1. Indonesia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Acne Drugs Market
12.1. South Korea Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Acne Drugs Market
13.1. Western Europe Acne Drugs Market Overview
13.2. Western Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Acne Drugs Market
14.1. UK Acne Drugs Market Overview
14.2. UK Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Acne Drugs Market
15.1. Germany Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Acne Drugs Market
16.4. France Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Acne Drugs Market
17.1. Eastern Europe Acne Drugs Market Overview
17.2. Eastern Europe Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Acne Drugs Market
18.1. Russia Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Acne Drugs Market
19.1. North America Acne Drugs Market Overview
19.2. North America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Acne Drugs Market
20.1. USA Acne Drugs Market Overview
20.2. USA Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Acne Drugs Market
21.1. South America Acne Drugs Market Overview
21.2. South America Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Acne Drugs Market
22.1. Brazil Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Acne Drugs Market
23.1. Middle East Acne Drugs Market Overview
23.2. Middle East Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Acne Drugs Market
24.1. Africa Acne Drugs Market Overview
24.2. Africa Acne Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Acne Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Acne Drugs Market Competitive Landscape And Company Profiles
25.1. Acne Drugs Market Competitive Landscape
25.2. Acne Drugs Market Company Profiles
25.2.1. ALLERGAN
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Galderma S.A.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Valeant Pharmaceutical International Inc.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Teva Pharmaceutical Industries Ltd.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Johnson & Johnson Services, Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Acne Drugs Market

27. Acne Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Acne Drugs Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ALLERGAN
  • Anterios Inc.
  • Bayer AG
  • Cipher
  • Foamix Pharmaceuticals
  • GlaxoSmithKline Plc.
  • MORE
Major players in the acne drugs market are ALLERGAN, Galderma S.A., Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd. and Johnson & Johnson Services, Inc.

The global acne drugs market is expected to decline from $4.6 billion in 2019 to $3.9 billion in 2020 at a compound annual growth rate (CAGR) of -15%. The decline is mainly because of drop in sales due to the lockdown measures to contain COVID-19 spread. Apart from restricting non-emergency medical services, new rules of the governments across the globe has forced many companies in the dermatology drug market to halt their business operations which has impacted the market growth. The market is then expected to recover and grow at a CAGR of 4.3% from 2021 and reach $5.7 billion in 2023.

The acne drugs market consists of sales of prescription acne drugs (Salicylic acid, Retin-A Micro, Onexton, and Solodyn) and related OTC non-prescription products (cleansers, lotions, gels, toners, masks and pads containing acne-fighting ingredients) which are used to treat skin diseases such as acne vulgaris and acne rosacea. Based on the type of acne, this market is segmented into inflammatory acne and Non-Inflammatory acne. Market in this report does not include the sales of drugs used for Dermatitis and Psoriasis.

North America was the largest region in the acne drugs market in 2018. This region is expected to remain the largest during the next five years. Among the countries, the USA acne drugs market was the largest. The acne drugs market in India is forecasted to register the highest CAGR during 2018-2023.

In March 2019, Allergan acquired Envy Medical Inc. o at an undisclosed price. This deal will help Allergan reinforce their goal towards providing customers with enhanced skin care solutions. Envy medicals' technology used in skin resurfacing procedures like Dermalinfusion, which is a non-surgical, non-invasive skin resurfacing system will immensely help Allergan gain a strong presence in the acne market. Allergan plc is a pharmaceutical company established in 1948 and headquartered in Dublin, Ireland.

Acne is a major problem worldwide, close to 90% of people suffer from some sort of acne. In America alone, close to 12 million people suffer from a severe acne problem, that can lead to scarring of the skin if left untreated, as a result many people purchase Acne care drugs and products.

The presence of alternatives for acne treatment is one of the restraint on the acne drugs market. Due to availability of multiple alternatives, patients tends to choose one amongst many options on the basis of price, side effects, duration and many more. This increases the competition and hence, the competition cuts down a significant portion of business for the acne drugs market. For example, some of the alternatives for the acne treatment apart from acne drugs are Ayurveda, home remedy, laser and photodynamic therapy and extraction of whiteheads and blackheads using special tools like needles and forceps.

Combination therapy is the latest trend in the acne market. Combination therapy is the process of combining two drugs with different mechanisms of action, such combinations of medication have a better efficacy and adherence when compared with monotherapy (the use of only a single drug by itself).The combination of a topical retinoid drug, which unclogs the pores, along with an antimicrobial drug, which is used to treat an infection is being used to treat acne. Example of combination therapy includes: Epiduo, Acanya, Ziana and Benzamycin produced by Galderma, Allergan, Medicis and Atrix respectively.

The stringent regulations concerning the usage of drugs to treat Acne has an impact on the acne drugs market. The regulations have become stringent due to the various side-effects and adverse events caused during the course of treatment. Recently in India, the Central Drugs Standard Control Organization (CDSCO) has issued a warning regarding the safety guidelines concerning the use of the oral drug, Isotretinoin. The CDSCO has directed the State and Union Territories’ drugs controllers to check the labeling of Isotretinoin drug and make the end users aware of the serious birth defects the drug may cause. Further, the Subject Expert Committee (SEC) for Dermatology and Allergy has recommended that the drug should be sold only on the prescription of a dermatologist, manufacturers should provide a package insert in local languages and the retail chemists should maintain the details of retail sale of the drug. Hence, these strict guidelines and regulations would impact the growth of acne drugs market.

An increase in the disposable income of people is one of the major drivers in the acne market. An increase in the disposable income is usually due to an improved economy leading to increased wages and salaries boosting healthcare expenditure. In 2018, Disposable Income in India increased 13.67% when compared to 2017 i.e. from 169 million INR to 192 million INR. Rise in disposable income increased expenditure on facial care products is expected to continue, thereby driving the market in the forecast period.
Note: Product cover images may vary from those shown
  • ALLERGAN
  • Galderma S.A.
  • Valeant Pharmaceutical International Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson Services Inc.
  • GlaxoSmithKline Plc.
  • Bayer AG
  • Stiefel Laboratories Inc.
  • Ranbaxy Laboratories Limited
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Cipher
  • Daiichi Sankyo Company Ltd
  • Guthy-Renker LLC
  • Medicis Pharmaceutical Corporation
  • Foamix Pharmaceuticals
  • BioPharmX Inc.
  • Roche Holding AG
  • F. Hoffmann-la Roche Ltd
  • Anterios Inc.
  • AndroScience
  • Oculus Innovative Sciences
  • Aqua Pharmaceuticals
  • Skinvisible Pharmaceuticals
  • Prestium Pharma Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll